Shanghai Desano Pharmaceutical Group Co., Ltd.
PrivateLast Round
Private Equity
Feb 2, 2023
Company Overview
Shanghai Desano Pharmaceutical Group Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Private Equity round in February 2023.
Shanghai Desano Pharmaceutical Group Co., Ltd. is a pharmaceutical company that engages in the research and development, manufacturing, and sales of high-quality pharmaceutical drugs, with a focus on treatments for HIV and malaria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Drug Discovery, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Desano Pharmaceutical Group Co., Ltd. Comparables
Compare Shanghai Desano Pharmaceutical Group Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hetero Group | 84% | |
| Anhui Biochem United Pharmaceutical Co., Ltd. | 81% | |
| Laurus Labs Limited | 81% |
For institutional investors. Book with your work email.
Shanghai Desano Pharmaceutical Group Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 2, 2023 | ||||
| Series A Extension | Mar 14, 2022 | ||||
| Strategic | Oct 31, 2014 | ||||
| Series A | Jan 1, 2011 | ||||
| Early Funding | Mar 1, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Shanghai Desano Pharmaceutical Group Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xingye Guoxin Asset Management | Private Equity |
| Lingang Blue Bay Capital | Series A Extension |
| Greenwoods Investments | Series A |
| PICC Capital Insurance Asset Management | Private Equity |
| Qiming Venture Partners | Early Funding, Private Equity |
| Zhenxiang Capital | Private Equity |
| 上海鼎嘉创业投资管理有限公司 | Strategic |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2023
Led by CICC Jiatai Tianjin Equity Investment Fund Partnership and PICC Capital.
- Mar 1, 2010
Qiming Venture Partners participated in the early funding round.
For institutional investors. Book with your work email.
Shanghai Desano Pharmaceutical Group Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Desano Pharmaceutical Group Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Desano Pharmaceutical Group Co., Ltd. a public or private company?
Shanghai Desano Pharmaceutical Group Co., Ltd. is a private company.
What is the current stock price of Shanghai Desano Pharmaceutical Group Co., Ltd.?
Shanghai Desano Pharmaceutical Group Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Desano Pharmaceutical Group Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Desano Pharmaceutical Group Co., Ltd. worth (valuation)?
Valuation information for Shanghai Desano Pharmaceutical Group Co., Ltd. is not publicly available.
Can I buy Shanghai Desano Pharmaceutical Group Co., Ltd. stock?
Shanghai Desano Pharmaceutical Group Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Desano Pharmaceutical Group Co., Ltd.'s last funding round?
Shanghai Desano Pharmaceutical Group Co., Ltd.'s most recent funding round was Private Equity on February 2, 2023.
Who are the main investors in Shanghai Desano Pharmaceutical Group Co., Ltd.?
Key investors in Shanghai Desano Pharmaceutical Group Co., Ltd. include PICC Capital Insurance Asset Management.
Will Shanghai Desano Pharmaceutical Group Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Desano Pharmaceutical Group Co., Ltd..
How can I track Shanghai Desano Pharmaceutical Group Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Desano Pharmaceutical Group Co., Ltd.'s shares on secondary markets.